Table 6 Associations of Asprosin levels with HTN among the study population.

From: Elevated asprosin in hypertension: evidence from an exploratory case-control study

Model

Coef β

SE

OR

95% CI

1

1.31

0.319

3.71

1.99–6.93

2

1.58

0.384

4.85

2.28–10.30

3

1.28

0.331

3.60

1.88–6.88

4

1.22

0.423

3.39

1.48–7.78

5

1.66

0.441

5.25

2.22–12.5

6

1.31

0.336

3.69

1.91–7.13

7

0.737

0.500

2.09

0.785–5.56

8

0.623

0.791

1.87

0.396–8.78

  1. Data is derived from ridge-penalized logistic regression, the ordinary hypothesis tests (p-values) and standard confidence intervals are not appropriate. Coefficients (β) and odds ratios (OR = e^β) are descriptive indicating the direction and relative strength of associations.
  2. Model 1: unadjusted model; model 2: adjusting for sociodemographic (age, sex, educational level, marital status, and family income); model 3: adjusted for anthropometric variables (BMI, BMI categories, WC, WC categories, and BMI and WC risk categories); model 4: adjusted for biochemical parameters (FINS, FBG, LogHOMA-IR, LogHOMA-β, and FBG categories; model 5: adjusted for lifestyle factors (physical activity level, stress level, and smoking status); model 6: adjusted for parental history of CVDs and HTN; model 7: adjusted for HTN medications; model 8: adjusted for all previous adjusted models (2–7).
  3. β: Penalized coefficient; SE: standard error; OR: odd ratio; CI: confidence interval.
Back to article page